Name: ceftriaxone sodium
Brand: CEFTRIAXONE

What is the patent landscape for Ceftriaxone, and when can generic versions of Ceftriaxone launch?

Ceftriaxone is a drug marketed by Qilu Pharm Co Ltd, Aurobindo Pharma Ltd, Sandoz Inc, Akorn Inc, Lupin, Teva Pharms Usa, Acs Dobfar, Hospira Inc, Hikma Farmaceutica, Fresenius Kabi Usa, Samson Medcl, Teva, Bedford, Agila Speclts, Sandoz, Facta Farma, Wockhardt, Cephazone Pharma, B Braun, Baxter Hlthcare, and Sagent Pharms. and is included in thirty-three NDAs.

The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

Summary for Tradename: CEFTRIAXONE

Patents:	0
Applicants:	21
NDAs:	33
Suppliers / Packagers: see list	27
Bulk Api Vendors: see list	22
Clinical Trials: see list	107
Patent Applications: see list	5,341
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	CEFTRIAXONE at DailyMed

Pharmacology for Tradename: CEFTRIAXONE

Ingredient-type	Cephalosporins
Drug Class	Cephalosporin Antibacterial

ADD ALERT

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Exclusivity Expiration
Cephazone Pharma	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065294-002	Mar 26, 2007		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Fresenius Kabi Usa	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065245-001	Feb 15, 2006		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Hospira Inc	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INJECTION	065231-001	Aug 2, 2005		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Lupin	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INJECTION	065263-001	Sep 12, 2006	AP	RX	No	No	► Subscribe	► Subscribe	► Subscribe
Sandoz	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065169-004	May 9, 2005	AP	RX	No	Yes	► Subscribe	► Subscribe	► Subscribe
Teva	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065262-001	Jun 29, 2006		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Bedford	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065465-003	Aug 18, 2008		DISCN	No	No	► Subscribe	► Subscribe	► Subscribe
Sandoz	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INJECTION	065168-001	May 17, 2005	AP	RX	No	Yes	► Subscribe	► Subscribe	► Subscribe
Sandoz	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065169-001	May 9, 2005	AP	RX	No	Yes	► Subscribe	► Subscribe	► Subscribe
Hospira Inc	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065230-003	Aug 2, 2005	AP	RX	No	No	► Subscribe	► Subscribe	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

BioPharmaceutical Business Intelligence

DrugPatentWatch Database Preview

CEFTRIAXONE Drug Profile

« Back to Dashboard